People: Transgene SA (TRNG.PA)

TRNG.PA on Paris Stock Exchange

23 Oct 2020
Change (% chg)

€-0.01 (-0.55%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Quemeneur, Eric 

Dr. Eric Quemeneur, Ph.D., has been Executive Vice President, Director of Research & Development and Member of the Management Committee at Transgene since 2014. Before joining Transgene he served as Director of Programs and Reclamation in the Life Sciences Department of the CEA, after a 20-year career in that organization. His responsibilities included managing the Research and Development programs and transferring them into applications, leading multi-disciplinary teams and developing national and international alliances. He is a biochemical engineer, INSA Lyon (1986), with a PhD in science, a D.U. degree in Industrial Pharmaceuticals from Universite Claude Bernard Lyon 1 and a Certificate in Research Management from Universite Pierre et Marie Curie – Paris VI. He is the author of some 80 publications in international scientific journals.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --